Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.1087
+0.0287 (35.88%)
At close: Apr 15, 2026
Oncology Pharma Market Cap
Oncology Pharma has a market cap or net worth of $4.2 million as of April 16, 2026. Its market cap has increased by 108,609.03% in one year.
Market Cap
4.20M
Enterprise Value
n/a
Revenue
10.21K
Ranking
n/a
PE Ratio
22.59
Stock Price
$0.11
Market Cap Chart
Since April 1, 2016, Oncology Pharma's market cap has increased from 27.10K to 4.20M, an increase of 15,408.08%. That is a compound annual growth rate of 65.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 3.09M | 1,900.00% |
| Dec 31, 2025 | 154.65K | 3,900.34% |
| Dec 31, 2024 | 3.87K | -50.01% |
| Dec 29, 2023 | 7.73K | -99.94% |
| Dec 30, 2022 | 13.06M | -90.45% |
| Dec 31, 2021 | 136.74M | 1,159.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nymox Pharmaceutical | 5.10M |
| Bioxytran | 5.10M |
| Mosaic ImmunoEngineering | 5.03M |
| Biomind Labs | 4.34M |
| GPL Holdings | 4.17M |
| Burzynski Research Institute | 3.29M |
| Vaccinex | 3.21M |
| ProtoKinetix | 2.84M |